Leg Cramps Pm Tablet
NDC Package 0363-7174-14
Package Information
Leg Cramps Pm (oyster shell calcium carbonate, crude, causticum, matricaria recutita, cinchona officinalis bark, copper, lycopodium clavatum spore, magnesium phosphate, dibasic trihydrate, toxicodendron pubescens leaf, silicon dioxide, and sulfur) tablets is • Suitable for adults and children ages 12 and over. This formulation utilizes a tablet delivery system. Marketed by Walgreen Company, this product is identified by NDC 0363-7174.
Identification & Billing
Clinical Specifications
- CAUSTICUM 12 [hp_X]/1
- CINCHONA OFFICINALIS BARK 3 [hp_X]/1
- COPPER 12 [hp_X]/1
- LYCOPODIUM CLAVATUM SPORE 12 [hp_X]/1
- MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE 6 [hp_X]/1
- MATRICARIA RECUTITA 6 [hp_X]/1
- OYSTER SHELL CALCIUM CARBONATE, CRUDE 12 [hp_X]/1
- SILICON DIOXIDE 12 [hp_X]/1
- SULFUR 6 [hp_X]/1
- TOXICODENDRON PUBESCENS LEAF 6 [hp_X]/1
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Copper - [CS]
- Copper-containing Intrauterine Device - [EPC] (Established Pharmacologic Class)
- Decreased Embryonic Implantation - [PE] (Physiologic Effect)
- Decreased Sperm Motility - [PE] (Physiologic Effect)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibit Ovum Fertilization - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
Regulatory & Marketing
Hierarchy Structure
- 0363 - Walgreen Company
- 0363-7174 - Leg Cramps Pm
- 0363-7174-14 - 1 BOTTLE, PLASTIC in 1 CARTON / 50 TABLET in 1 BOTTLE, PLASTIC
- 0363-7174 - Leg Cramps Pm
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0363-7174-14 identifies a specific commercial package of 1 bottle, plastic in 1 carton / 50 tablet in 1 bottle, plastic of Leg Cramps Pm, a human over the counter drug labeled by Walgreen Company. This tablet is formulated for oral use and contains causticum; cinchona officinalis bark; copper; lycopodium clavatum spore; magnesium phosphate, dibasic trihydrate; matricaria recutita; oyster shell calcium carbonate, crude; silicon dioxide; sulfur; toxicodendron pubescens leaf as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Walgreen Company on May 21, 2023. The current certification is valid through December 31, 2026.
How is this Walgreen Company product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00363717414. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.